Shimadzu buys CDMO AlsaChim

By Staff reporter

- Last updated on GMT


Related tags: English-language films

Shimadzu has acquired French radiolabelling contractor AlsaChim. 

The deal – financial terms of which were not disclosed – adds AlsaChim’s range of isotope-labelled standards compounds, metabolites and pharmaceutical related substances to Shimadzu portfolio of analytical standards.

Shimadzu cited AlsaChim’s presence in the clinical trial supply and analytical sectors as an important driver for the takeover. The Japanese firm also predicted its analytical testing kits business would benefit from the acquisition.

Bjoern-Thoralf Erxleben, Senior Manager Analytic Shimadzu Europa, said: “With AlsaChim, we have a strong partner in our organization who is able to finalize and validate new application kits and utilize the developments done by EUIC and transfer them into ready-to-use products​.”

Shimadzu also predicted that AlasCHim – which will retain its name – will expand its customer-base.

Related news

Related products

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers